Richard J. Turner
Geen lopende functies
Loopbaan van Richard J. Turner
Eerdere bekende functies van Richard J. Turner
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Transcriptogen Ltd.
 Transcriptogen Ltd. BiotechnologyHealth Technology Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom. | Directeur/Bestuurslid | - | 17-06-2017 |
| Algemeen Directeur | - | 17-06-2017 | |
Catalyst Venture Partners Ltd.
 Catalyst Venture Partners Ltd. Investment ManagersFinance Catalyst Venture Partners Ltd. (CVP) is a London-based independent corporate finance advisory and private equity partnership established in 1999 by a group of technology entrepreneurs. Catalyst Venture Partners Ltd. | Algemeen Directeur | 29-04-2011 | - |
| Oprichter | 29-04-2011 | - | |
| Private Equity Investor | 01-01-1999 | 01-09-2010 | |
| Corporate Officer/Principal | 01-01-1999 | 29-04-2011 |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
Operationeel
| Chief Executive Officer | 2 |
| Founder | 1 |
| Private Equity Investor | 1 |
Sectoraal
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Catalyst Venture Partners Ltd.
Catalyst Venture Partners Ltd. Investment ManagersFinance Catalyst Venture Partners Ltd. (CVP) is a London-based independent corporate finance advisory and private equity partnership established in 1999 by a group of technology entrepreneurs. Catalyst Venture Partners Ltd. | Finance |
Transcriptogen Ltd.
Transcriptogen Ltd. BiotechnologyHealth Technology Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Richard J. Turner
- Ervaring
